Quick Answer
Werewolf Therapeutics, Inc. reported Operating Income of -$60.68 million for fiscal year 2025.
Werewolf Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$60.68M | +17.6% |
| 2024 | -$73.59M | -81.7% |
| 2023 | -$40.50M | +27.7% |
| 2022 | -$56.06M | -11.9% |
| 2021 | -$50.09M | -123.6% |
| 2020 | -$22.40M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.73M | +8.2% | +10.4% |
| June 30, 2025 | -$17.54M | +7.5% | +2.5% |
| March 31, 2025 | -$17.99M | -4.8% | -5.1% |
| September 30, 2024 | -$17.12M | -85.1% | +9.7% |
| June 30, 2024 | -$18.96M | -212.5% | -10.5% |
| March 31, 2024 | -$17.16M | -40.4% | -85.5% |
| September 30, 2023 | -$9.25M | +26.2% | -52.5% |
| June 30, 2023 | -$6.07M | +59.5% | +50.4% |
- Werewolf Therapeutics, Inc. showed an increase of +17.6% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Werewolf Therapeutics, Inc.’s operating income has declined by 170.8% (from -$22.40 million to -$60.68 million).
- The most recent figure is from Werewolf Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: